Deborah Hartman

No two days are quite the same," says Deborah Hartman, director of lead discovery in central nervous system and pain research at AstraZeneca in Wilmington, Del. Hartman, who started out as a bench scientist, is now a manager in charge of about 50 people working together on discovering new drugs for CNS disease targets.

Written byKate Fodor
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

No two days are quite the same," says Deborah Hartman, director of lead discovery in central nervous system and pain research at AstraZeneca in Wilmington, Del. Hartman, who started out as a bench scientist, is now a manager in charge of about 50 people working together on discovering new drugs for CNS disease targets.

"In this role, there's a mixture of scientific-, business-, and personnel-related activities," Hartman notes. She oversees everything from lab safety to budget management, but she is still a scientist at heart. "I no longer work in the lab myself, but I think my favorite part of the day is the opportunity to discuss results that have come out of the lab or catch up on scientific literature," she says.

Hartman's affinity for science dates back to her childhood. "Since I was a kid, I was very interested in science, everything from medicine to space exploration," she ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies